Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Sylvia, Louisa"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 26
Tytuł:
Web-Based Mindfulness-Based Interventions for Well-being: Randomized Comparative Effectiveness Trial.
Autorzy:
Sylvia LG; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.; Harvard University, Cambridge, MA, United States.
Lunn MR; Stanford University School of Medicine, Stanford, CA, United States.
Obedin-Maliver J; Stanford University School of Medicine, Stanford, CA, United States.
McBurney RN; Accelerated Cure Project for Multiple Sclerosis, Waltham, MA, United States.
Nowell WB; Global Healthy Living Foundation, Upper Nyack, NY, United States.
Nosheny RL; University of California San Francisco School of Medicine, San Francisco, CA, United States.
Mularski RA; Kaiser Permanente Center for Health Research Northwest Region, Portland, OR, United States.
Long MD; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
Merkel PA; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States.
Pletcher MJ; University of California San Francisco School of Medicine, San Francisco, CA, United States.
Tovey RE; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
Scalchunes C; Immune Deficiency Foundation, Towson, MD, United States.
Sutphen R; University of South Florida, Tampa, FL, United States.
Martin AS; Parent Project Muscular Dystrophy, Washington, DC, United States.
Horn EJ; Phelan-McDermid Syndrome Foundation, Osprey, FL, United States.
O'Boyle M; Phelan-McDermid Syndrome Foundation, Osprey, FL, United States.
Pitch L; ImproveCareNow Inc., Burlington, VT, United States.
Seid M; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Redline S; Brigham and Women's Hospital, Boston, MA, United States.
Greenebaum S; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
George N; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
French NJ; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
Faria CM; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
Puvanich N; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
Rabideau DJ; Biostatistics, Massachusetts General Hospital, Boston, MA, United States.
Selvaggi CA; Biostatistics, Massachusetts General Hospital, Boston, MA, United States.
Yu C; Biostatistics, Massachusetts General Hospital, Boston, MA, United States.
Faraone SV; State University of New York Upstate Medical University, Syracuse, NY, United States.
Venkatachalam S; Global Healthy Living Foundation, Upper Nyack, NY, United States.
McCall D; Health eHeart Alliance, San Francisco, CA, United States.
Terry SF; Genetic Alliance, Damascus, MD, United States.
Deckersbach T; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
Nierenberg AA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.; Harvard University, Cambridge, MA, United States.
Pokaż więcej
Źródło:
Journal of medical Internet research [J Med Internet Res] 2022 Sep 12; Vol. 24 (9), pp. e35620. Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Cognitive Behavioral Therapy*
Mindfulness*
Psychotherapy, Group*
Female ; Humans ; Infant, Newborn ; Internet ; Treatment Outcome
Czasopismo naukowe
Pełny tekstSzczegóły
Tytuł:
Reports of the demise of CBT for bipolar disorder have been greatly exaggerated: a response to Samamé.
Autorzy:
Katz D; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Miklowitz D; University of California, Los Angeles, California, USA.; University of Oxford, Oxford, UK.
Gaudiano B; Brown University, Providence, Rhode Island, USA.; Butler Hospital, Providence, Rhode Island, USA.; Providence VA Medical Center, Providence, Rhode Island, USA.
Weinstock L; Brown University, Providence, Rhode Island, USA.
Gold A; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Boston University, Boston, Massachusetts, USA.
Nierenberg A; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Sylvia L; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2022 Aug; Vol. 24 (5), pp. 472-473. Date of Electronic Publication: 2022 Feb 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Comment
MeSH Terms:
Bipolar Disorder*/therapy
Cognitive Behavioral Therapy*
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder.
Autorzy:
Wrobel AL; IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.; Orygen, Parkville, Victoria, Australia.
Köhler-Forsberg O; Psychosis Research Unit, Aarhus University Hospital Psychiatry, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Sylvia LG; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Russell SE; IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.
Dean OM; IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
Cotton SM; Orygen, Parkville, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
Thase M; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Calabrese JR; Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio, USA.
Deckersbach T; Diploma Hochschule, University of Applied Sciences, Bad Sooden-Allendorf, Germany.
Tohen M; Department of Psychiatry, University of New Mexico Health Science Center, Albuquerque, New Mexico, USA.
Bowden CL; Department of Psychiatry, University of Texas Health Science Center, San Antonio, Texas, USA.
McInnis MG; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.
Kocsis JH; Department of Psychiatry, Weill Cornell Medical College, New York, New York, USA.
Friedman ES; Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Ketter TA; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.
Shelton RC; Department of Psychiatry, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Ostacher MJ; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.; Department of Psychiatry, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
Iosifescu DV; NYU School of Medicine and Nathan Kline Institute, New York, New York, USA.
Berk M; IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.; Orygen, Parkville, Victoria, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.; Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.
Turner A; IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
Nierenberg AA; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2022 Jun; Vol. 145 (6), pp. 615-627. Date of Electronic Publication: 2022 Mar 11.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Adverse Childhood Experiences*
Antipsychotic Agents*/therapeutic use
Bipolar Disorder*/drug therapy
Humans ; Lithium/therapeutic use ; Outpatients ; Quetiapine Fumarate/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cigarette smokers with a mood symptom history enrolled in a physical activity trial.
Autorzy:
Gold AK; Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts, USA.
Albury EA; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
Stromberg A; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
French NJ; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
Peters AT; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Katz D; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Nierenberg AA; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Sylvia LG; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2021 Dec; Vol. 23 (8), pp. 842-843. Date of Electronic Publication: 2021 Oct 13.
Typ publikacji:
Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Bipolar Disorder*
Tobacco Products*
Affect ; Exercise ; Humans ; Smokers
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Pilot Study of a Stress Management Program for Incarcerated Veterans.
Autorzy:
Sylvia LG; Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA.; Dauten Family Center for Bipolar Treatment Innovation, MGH, Boston, MA 02114, USA.
Chudnofsky R; Benson-Henry Institute for Mind Body Medicine, MGH, Boston, MA 02114, USA.
Fredriksson S; Red Sox Foundation and Massachusetts General Hospital (MGH) Home Base Program, Charlestown, MA 02129, USA.
Xu B; Red Sox Foundation and Massachusetts General Hospital (MGH) Home Base Program, Charlestown, MA 02129, USA.
McCarthy MD; Red Sox Foundation and Massachusetts General Hospital (MGH) Home Base Program, Charlestown, MA 02129, USA.
Francona J; Red Sox Foundation and Massachusetts General Hospital (MGH) Home Base Program, Charlestown, MA 02129, USA.
Hart BR; Red Sox Foundation and Massachusetts General Hospital (MGH) Home Base Program, Charlestown, MA 02129, USA.
Millstein R; Red Sox Foundation and Massachusetts General Hospital (MGH) Home Base Program, Charlestown, MA 02129, USA.
Mehta DH; Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA.; Benson-Henry Institute for Mind Body Medicine, MGH, Boston, MA 02114, USA.; Red Sox Foundation and Massachusetts General Hospital (MGH) Home Base Program, Charlestown, MA 02129, USA.
Park ER; Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA.; Benson-Henry Institute for Mind Body Medicine, MGH, Boston, MA 02114, USA.
Fricchione GL; Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA.; Benson-Henry Institute for Mind Body Medicine, MGH, Boston, MA 02114, USA.; Red Sox Foundation and Massachusetts General Hospital (MGH) Home Base Program, Charlestown, MA 02129, USA.
Pokaż więcej
Źródło:
Military medicine [Mil Med] 2021 Nov 02; Vol. 186 (11-12), pp. 1061-1065.
Typ publikacji:
Journal Article
MeSH Terms:
Mindfulness*
Prisoners*
Veterans*
Female ; Humans ; Male ; Pilot Projects ; Quality of Life ; Stress, Psychological/therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A surrogate measure for patient reported symptom remission in administrative data.
Autorzy:
Alemi F; Dept. of Health Administration and Policy, College of Health and Human Services, George Mason University, Fairfax, USA. .
Aljuaid M; Dept. of Health Administration and Policy, College of Health and Human Services, George Mason University, Fairfax, USA.
Durbha N; Dept. of Health Administration and Policy, College of Health and Human Services, George Mason University, Fairfax, USA.
Yousefi M; School of Nursing, College of Health and Human Services, George Mason University, Fairfax, USA.
Min H; Dept. of Health Administration and Policy, College of Health and Human Services, George Mason University, Fairfax, USA.
Sylvia LG; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Nierenberg AA; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2021 Mar 04; Vol. 21 (1), pp. 121. Date of Electronic Publication: 2021 Mar 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antidepressive Agents*/therapeutic use
Patient Reported Outcome Measures*
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials.
Autorzy:
Köhler-Forsberg O; Psychosis Research Unit and the Department of Affective Disorders, Aarhus University Psychiatry Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Sylvia LG; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Fung V; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts.
Overhage L; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts.
Thase M; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Calabrese JR; Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio.
Deckersbach T; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Tohen M; Department of Psychiatry, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.
Bowden CL; Department of Psychiatry, University of Texas Health Science Center, San Antonio, Texas.
McInnis M; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.
Kocsis JH; Department of Psychiatry, Weill Cornell Medical College, New York, New York.
Friedman ES; Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Ketter TA; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
McElroy SL; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio.; Department of Psychiatry, Lindner Center of HOPE, Mason, Ohio.
Shelton RC; Department of Psychiatry, University of Alabama at Birmingham, Birmingham, Alabama.
Ostacher MJ; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Iosifescu DV; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Nierenberg AA; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło:
Depression and anxiety [Depress Anxiety] 2021 Feb; Vol. 38 (2), pp. 114-123. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Bipolar Disorder*/drug therapy
Bipolar Disorder*/epidemiology
Antidepressive Agents/therapeutic use ; Humans ; Outpatients
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Call to action regarding the vascular-bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders.
Autorzy:
Goldstein BI; Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Departments of Psychiatry & Pharmacology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Baune BT; Department of Psychiatry and Psychotherapy, University of Münster, Münster, Germany.; Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australia.; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.
Bond DJ; Department of Psychiatry and Behavioral Science, University of Minnesota Medical School, Minneapolis, MN, USA.
Chen PH; Department of Psychiatry, Taipei Medical University Hospital, Taipei, Taiwan.; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Eyler L; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
Fagiolini A; Department of Psychiatry, University of Siena, Siena, Italy.
Gomes F; Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada.
Hajek T; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.; National Institute of Mental Health, Klecany, Czech Republic.
Hatch J; Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Departments of Psychiatry & Pharmacology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
McElroy SL; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Lindner Center of HOPE, Mason, OH, USA.
McIntyre RS; Departments of Psychiatry & Pharmacology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
Prieto M; Department of Psychiatry, Faculty of Medicine, Universidad de los Andes, Santiago, Chile.; Mental Health Service, Clínica Universidad de los Andes, Santiago, Chile.; Department of Psychiatry and Psychology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Sylvia LG; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA.
Tsai SY; Department of Psychiatry, Taipei Medical University Hospital, Taipei, Taiwan.; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Kcomt A; Hope+Me-Mood Disorders Association of Ontario, Toronto, ON, Canada.
Fiedorowicz JG; Departments of Psychiatry, Internal Medicine, & Epidemiology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2020 Aug; Vol. 22 (5), pp. 440-460. Date of Electronic Publication: 2020 Jun 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Bipolar Disorder*/complications
Cardiovascular Diseases*/epidemiology
Adolescent ; Adult ; Advisory Committees ; Humans ; Risk Factors ; Smoking
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bipolar disorder as a condition of heterogeneity: Embracing an adaptive psychosocial approach.
Autorzy:
Gold AK; Department of Psychological and Brain Sciences, Boston University, Boston, MA, USA.
Otto MW; Department of Psychological and Brain Sciences, Boston University, Boston, MA, USA.
Sylvia LG; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2020 Jun; Vol. 22 (4), pp. 416-417. Date of Electronic Publication: 2020 Mar 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Comment
MeSH Terms:
Bipolar Disorder*
Cognitive Behavioral Therapy ; Humans ; Psychotherapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predictive modeling for response to lithium and quetiapine in bipolar disorder.
Autorzy:
Kim TT; University of Pennsylvania, Philadelphia, Pennsylvania.
Dufour S; The Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston, Massachusetts.
Xu C; University of Pennsylvania, Philadelphia, Pennsylvania.
Cohen ZD; University of Pennsylvania, Philadelphia, Pennsylvania.
Sylvia L; The Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Deckersbach T; The Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
DeRubeis RJ; University of Pennsylvania, Philadelphia, Pennsylvania.
Nierenberg AA; The Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2019 Aug; Vol. 21 (5), pp. 428-436. Date of Electronic Publication: 2019 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Models, Biological*
Antipsychotic Agents/*administration & dosage
Bipolar Disorder/*drug therapy
Lithium Compounds/*administration & dosage
Quetiapine Fumarate/*administration & dosage
Adult ; Attention Deficit Disorder with Hyperactivity/complications ; Bipolar Disorder/complications ; Comorbidity ; Female ; Humans ; Machine Learning ; Male ; Precision Medicine ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder.
Autorzy:
Behrendt-Møller I; Mental Health Centre Copenhagen, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Madsen T; Mental Health Centre Copenhagen, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Sørensen HJ; Mental Health Centre Copenhagen, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Sylvia L; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Friedman ES; Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Shelton RC; Department of Psychiatry, University of Alabama at Birmingham, Birmingham, Alabama.
Bowden CL; Department of Psychiatry, University of Texas Health Science Center, San Antonio, Texas.
Calabrese JR; Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio.
McElroy SL; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio.; Lindner Center of HOPE, Mason, Ohio.
Ketter TA; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Reilly-Harrington NA; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Gao K; Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio.
Thase M; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
V Bobo W; Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota.
Tohen M; Department of Psychiatry, University of New Mexico Health Science Center, Albuquerque, New Mexico.
McInnis M; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.
Kamali M; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
Kocsis JH; Department of Psychiatry, Weill Cornell Medical College, New York, New York.
Deckersbach T; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Köhler-Forsberg O; Mental Health Centre Copenhagen, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.; Psychosis Research Unit, Aarhus University Hospital, Risskov, Denmark.
Nierenberg AA; Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2019 Jun; Vol. 21 (4), pp. 350-360. Date of Electronic Publication: 2018 Dec 01.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Bipolar Disorder*/diagnosis
Bipolar Disorder*/drug therapy
Bipolar Disorder*/psychology
Depression*/diagnosis
Depression*/epidemiology
Depression*/psychology
Lithium Compounds/*therapeutic use
Quetiapine Fumarate/*therapeutic use
Adult ; Antidepressive Agents/therapeutic use ; Drug Monitoring/methods ; Female ; Humans ; Male ; Prevalence ; Prognosis ; Psychiatric Status Rating Scales ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Deficits in frontoparietal activation and anterior insula functional connectivity during regulation of cognitive-affective interference in bipolar disorder.
Autorzy:
Ellard KK; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Gosai AK; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Felicione JM; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Peters AT; Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois.
Shea CV; Department of Neuroscience, Boston University, Boston, Massachusetts.
Sylvia LG; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Nierenberg AA; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Widge AS; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Dougherty DD; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Deckersbach T; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2019 May; Vol. 21 (3), pp. 244-258. Date of Electronic Publication: 2018 Nov 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Bipolar Disorder/*psychology
Cognition/*physiology
Emotions/*physiology
Parietal Lobe/*physiopathology
Prefrontal Cortex/*physiopathology
Adult ; Cerebral Cortex/physiopathology ; Female ; Humans ; Magnetic Resonance Imaging/methods ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment outcomes of acute bipolar depressive episode with psychosis.
Autorzy:
Caldieraro MA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Serviço de Psiquiatria, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brasil.
Dufour S; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Sylvia LG; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Gao K; Mood Disorders Program, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Ketter TA; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Bobo WV; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Walsh S; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Janos J; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Tohen M; Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Reilly-Harrington NA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
McElroy SL; Lindner Center of HOPE, Mason, OH, USA.; Deparment of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Shelton RC; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Bowden CL; Department of Psychiatry, University of Texas Health Science Center, San Antonio, TX, USA.
Deckersbach T; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Nierenberg AA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
Depression and anxiety [Depress Anxiety] 2018 May; Vol. 35 (5), pp. 402-410. Date of Electronic Publication: 2018 Jan 12.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Bipolar Disorder*/drug therapy
Bipolar Disorder*/epidemiology
Bipolar Disorder*/physiopathology
Psychotic Disorders*/drug therapy
Psychotic Disorders*/epidemiology
Psychotic Disorders*/physiopathology
Treatment Outcome*
Antimanic Agents/*pharmacology
Antipsychotic Agents/*pharmacology
Lithium Compounds/*pharmacology
Quetiapine Fumarate/*pharmacology
Adult ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Substance use comorbidity in bipolar disorder: A qualitative review of treatment strategies and outcomes.
Autorzy:
Gold AK; Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts.
Otto MW; Department of Psychological and Brain Sciences, Boston University, Boston, Massachusetts.
Deckersbach T; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Sylvia LG; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Nierenberg AA; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Kinrys G; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło:
The American journal on addictions [Am J Addict] 2018 Apr; Vol. 27 (3), pp. 188-201.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Bipolar Disorder*/epidemiology
Bipolar Disorder*/psychology
Bipolar Disorder*/therapy
Psychiatric Rehabilitation*
Substance-Related Disorders*/epidemiology
Substance-Related Disorders*/psychology
Substance-Related Disorders*/therapy
Psychotherapy, Group/*methods
Comorbidity ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Poor quality of life and functioning in bipolar disorder.
Autorzy:
Sylvia LG; Department of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, USA. .; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA. .
Montana RE; Department of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, USA.
Deckersbach T; Department of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.
Thase ME; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Tohen M; Department of Psychiatry and Behavioral Sciences, University of New Mexico, Health Sciences Center, Albuquerque, NM, USA.
Reilly-Harrington N; Department of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.
McInnis MG; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Kocsis JH; Department of Psychiatry, Weill Cornell Medicine, New York City, NY, USA.
Bowden C; Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Calabrese J; Bipolar Disorders Research Center, University Hospital's Case Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Gao K; Bipolar Disorders Research Center, University Hospital's Case Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Ketter T; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Shelton RC; Department of Psychiatry, University of Alabama Birmingham School of Medicine, Birmingham, AL, USA.
McElroy SL; Lindner Center of HOPE, Mason, OH, USA.; Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Friedman ES; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Rabideau DJ; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Nierenberg AA; Department of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.
Pokaż więcej
Źródło:
International journal of bipolar disorders [Int J Bipolar Disord] 2017 Dec; Vol. 5 (1), pp. 10. Date of Electronic Publication: 2017 Mar 27.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder.
Autorzy:
Köhler-Forsberg O; Psychosis Research Unit, Aarhus University Hospital, Risskov, Denmark.
Sylvia L; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Thase M; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Calabrese JR; Department of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
Deckersbach T; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Tohen M; Department of Psychiatry, University of New Mexico Health Science Center, Albuquerque, NM, USA.
Bowden CL; Department of Psychiatry, University of Texas Health Science Center, San Antonio, TX, USA.
McInnis M; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Kocsis JH; Department of Psychiatry, Weill Cornell Medical College, New York, NY, USA.
Friedman ES; Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Ketter TA; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
McElroy S; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH.; Lindner Center of HOPE, Mason, OH, USA.
Shelton RC; Department of Psychiatry, University of Alabama at Birmingham, Birmingham, AL, USA.
Nierenberg AA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
Depression and anxiety [Depress Anxiety] 2017 Mar; Vol. 34 (3), pp. 281-290. Date of Electronic Publication: 2017 Jan 30.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Acetaminophen/*pharmacology
Analgesics, Non-Narcotic/*pharmacology
Anti-Inflammatory Agents, Non-Steroidal/*pharmacology
Antipsychotic Agents/*therapeutic use
Bipolar Disorder/*drug therapy
Adolescent ; Adult ; Bipolar Disorder/complications ; Bipolar Disorder/psychology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Pain/complications ; Pain/drug therapy ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Study protocol for a systematic review of evidence for lifestyle interventions targeting smoking, sleep, alcohol/other drug use, physical activity, and healthy diet in people with bipolar disorder.
Autorzy:
Kay-Lambkin FJ; National Health and Medical Research Council Centre for Research Excellence in Mental Health and Substance Use, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia. .; Priority Research Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Newcastle, Australia. .
Thornton L; National Health and Medical Research Council Centre for Research Excellence in Mental Health and Substance Use, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Lappin JM; Black Dog Institute, School of Psychiatry, University of New South Wales, Sydney, Australia.
Hanstock T; Priority Research Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Newcastle, Australia.; School of Psychology, University of Newcastle, Newcastle, Australia.
Sylvia L; Department of Psychiatry, Harvard Medical School, Boston, USA.
Jacka F; IMPACT Strategic Research Centre (Innovation in Mental and Physical Health and Clinical Treatment), Deakin University, Waurn Ponds, Australia.
Baker AL; Priority Research Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Newcastle, Australia.
Berk M; IMPACT Strategic Research Centre (Innovation in Mental and Physical Health and Clinical Treatment), Deakin University, Waurn Ponds, Australia.
Mitchell PB; Black Dog Institute, School of Psychiatry, University of New South Wales, Sydney, Australia.
Callister R; School of Biomedical Sciences and Pharmacy, Faculty of Medicine, The University of Newcastle, Newcastle, Australia.
Rogers N; Brain and Mind Institute, University of Sydney, Sydney, Australia.
Webster S; National Health and Medical Research Council Centre for Research Excellence in Mental Health and Substance Use, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Dennis S; School of Psychology, University of Newcastle, Newcastle, Australia.
Oldmeadow C; CReDITSS, Hunter Medical Research Institute, Newcastle, Australia.
MacKinnon A; The University of Melbourne, Melbourne, Australia.
Doran C; CReDITSS, Hunter Medical Research Institute, Newcastle, Australia.
Turner A; Priority Research Centre for Translational Neuroscience and Mental Health, The University of Newcastle, Newcastle, Australia.; IMPACT Strategic Research Centre (Innovation in Mental and Physical Health and Clinical Treatment), Deakin University, Waurn Ponds, Australia.
Hunt S; National Health and Medical Research Council Centre for Research Excellence in Mental Health and Substance Use, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Pokaż więcej
Źródło:
Systematic reviews [Syst Rev] 2016 Jul 05; Vol. 5 (1), pp. 106. Date of Electronic Publication: 2016 Jul 05.
Typ publikacji:
Journal Article
MeSH Terms:
Diet, Healthy*
Exercise*
Risk Reduction Behavior*
Sleep*
Smoking Prevention*
Alcohol Drinking/*prevention & control
Bipolar Disorder/*psychology
Substance-Related Disorders/*prevention & control
Alcohol Drinking/adverse effects ; Alcohol Drinking/psychology ; Bipolar Disorder/complications ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/prevention & control ; Diabetes Mellitus/etiology ; Diabetes Mellitus/prevention & control ; Evidence-Based Practice ; Feeding Behavior/psychology ; Humans ; Risk Factors ; Smoking/adverse effects ; Smoking/psychology ; Systematic Reviews as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
SPECIFIC MOOD SYMPTOMS CONFER RISK FOR SUBSEQUENT SUICIDAL IDEATION IN BIPOLAR DISORDER WITH AND WITHOUT SUICIDE ATTEMPT HISTORY: MULTI-WAVE DATA FROM STEP-BD.
Autorzy:
Stange JP; Department of Psychology, Temple University, Philadelphia, Pennsylvania.
Kleiman EM; Department of Psychology, Harvard University, Cambridge, Massachusetts.
Sylvia LG; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Magalhães PV; National Institute for Translational Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Brazil.
Berk M; IMPACT Strategic Research Centre, School of Medicine, Deakin University, Barwon Health, Geelong, Victoria, Australia.; Orygen, The National Centre of Excellence in Youth Mental Health, Department of Psychiatry and The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia.
Nierenberg AA; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Deckersbach T; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło:
Depression and anxiety [Depress Anxiety] 2016 Jun; Vol. 33 (6), pp. 464-72. Date of Electronic Publication: 2016 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Suicidal Ideation*
Suicide, Attempted*/statistics & numerical data
Bipolar Disorder/*physiopathology
Mood Disorders/*physiopathology
Adult ; Bipolar Disorder/epidemiology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Mood Disorders/epidemiology ; Risk
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.
Autorzy:
Sylvia LG; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Gold AK; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
Stange JP; Department of Psychology, Temple University, Philadelphia, Pennsylvania.
Peckham AD; Department of Psychology, University of California, Berkeley, California.
Deckersbach T; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Calabrese JR; Bipolar Disorders Research Center, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio.
Weiss RD; Harvard Medical School, Boston, Massachusetts.; Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, Massachusetts.
Perlis RH; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Nierenberg AA; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Ostacher MJ; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Pokaż więcej
Źródło:
The American journal on addictions [Am J Addict] 2016 Mar; Vol. 25 (2), pp. 94-8. Date of Electronic Publication: 2016 Feb 19.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms:
Alcohol-Related Disorders/*complications
Alcohol-Related Disorders/*drug therapy
Bipolar Disorder/*complications
Fructose/*analogs & derivatives
Alcohol Drinking/drug therapy ; Diagnosis, Dual (Psychiatry) ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Fructose/therapeutic use ; Humans ; Male ; Middle Aged ; Neuroprotective Agents/therapeutic use ; Topiramate ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
Autorzy:
Sylvia LG; Bipolar Clinic and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA.
Shelton RC
Kemp DE
Bernstein EE
Friedman ES
Brody BD
McElroy SL
Singh V
Tohen M
Bowden CL
Ketter TA
Deckersbach T
Thase ME
Reilly-Harrington NA
Nierenberg AA
Rabideau DJ
Kinrys G
Kocsis JH
Bobo WV
Kamali M
McInnis MG
Calabrese JR
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2015 Mar; Vol. 17 (2), pp. 212-23. Date of Electronic Publication: 2014 Aug 16.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Bipolar Disorder/*epidemiology
Cardiovascular Diseases/*epidemiology
Diabetes Mellitus/*epidemiology
Hyperlipidemias/*epidemiology
Metabolic Syndrome/*epidemiology
Smoking/*epidemiology
Substance-Related Disorders/*epidemiology
Adult ; Antimanic Agents/therapeutic use ; Antipsychotic Agents/therapeutic use ; Asthma/epidemiology ; Bipolar Disorder/drug therapy ; Bipolar Disorder/psychology ; Comorbidity ; Comparative Effectiveness Research ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Humans ; Lithium Compounds/therapeutic use ; Male ; Middle Aged ; Neoplasms/epidemiology ; Quetiapine Fumarate/therapeutic use ; Seizures/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 26

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies